Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Xianjin Zou"'
Publikováno v:
Annals of diagnostic pathology. 29
Objective: To establish a time-resolved fluoroimmunoassay (TRFIA) method to detect p16INK4a. Methods: 119 cases of exfoliative cells following Thinprep cytologic test (TCT) test were selected for TRFIA and biopsy tissues of these patients according t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::756e2e83ffb264c7fb8aebcba875e605
https://pubmed.ncbi.nlm.nih.gov/28807346
https://pubmed.ncbi.nlm.nih.gov/28807346
Publikováno v:
Die Pharmazie. 69(1)
PIK3CA is probably the most commonly mutated kinase in several malignant tumors. Activation of class I phosphatidylinositol 3' kinase (PI3K) regulates tumor proliferation, survival, etc. This study sought to identify whether the pan-inhibitor has mor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::77041e0ebab904d1188e56384b09915b
https://pubmed.ncbi.nlm.nih.gov/24601221
https://pubmed.ncbi.nlm.nih.gov/24601221
Publikováno v:
Chemotherapy. 58(4)
Background: The phosphatidylinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway is a key potential target in breast cancer therapy. Because some cancer cell lines are resistant to mTOR inhibition, we combined the mTOR inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b790036080896ceb239bd790d308ab6e
https://pubmed.ncbi.nlm.nih.gov/23006739
https://pubmed.ncbi.nlm.nih.gov/23006739